Completed PHASE2 INTERVENTIONAL 1-arm NCT00465608

Propranolol in Post Traumatic Stress Disorder (Reductrauma)

Reduction of the Traumatic Memory by Reconsolidation Blockade: A Pilot Study

Sponsor: University Hospital, Toulouse

Conditions Post-Traumatic Stress Disorder

Interventions propranolol

Updated 5 times since 2017 Last updated: Jan 6, 2009 Started: Apr 30, 2007 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00465608, this PHASE2 trial focuses on Post-Traumatic Stress Disorder and remains completed. Sponsored by University Hospital, Toulouse, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Toulouse

Data source: University Hospital, Toulouse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France